Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | G1T38 |
| Trade Name | |
| Synonyms | Lerociclib |
| Drug Descriptions |
Lerociclib (G1T38) is a selective CDK4/6 inhibitor, which results in cell cycle arrest and tumor cell death (PMID: 32130619). |
| DrugClasses | CDK4/6 Inhibitor 14 |
| CAS Registry Number | 1628256-23-4 |
| NCIT ID | C138165 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Enzalutamide + G1T38 | Enzalutamide G1T38 | 0 | 0 |
| Fulvestrant + G1T38 | Fulvestrant G1T38 | 0 | 1 |
| G1T38 | G1T38 | 0 | 0 |
| G1T38 + G1T48 | G1T38 G1T48 | 0 | 0 |
| G1T38 + Letrozole | G1T38 Letrozole | 0 | 2 |
| G1T38 + Osimertinib | G1T38 Osimertinib | 0 | 1 |
| G1T38 + SCH772984 | G1T38 SCH772984 | 0 | 0 |